US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,569.77

-2.7697-0.18%

Number of Gainers:2

Number of Losers:5

Number of Flat:- -

PE:- -

High:1,588.44

Open:1,572.59

Low:1,566.72

Close:1,572.54

Volume:49.63M

Turnover:4.82B

Market Cap:1.64T

Float Cap:1.57T

Loading ...

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026

Why Amgen Stock is Dropping After Swiss Rival's Trial Setback

Amgen Falls After Novartis Trial Setback, BMO Downgrade

Novo Nordisk Phase 3 Trial Meets Primary Endpoint for Child Obesity Drug

MT Newswires Live

Stocks to Watch: Amgen, Nike, Bloom Energy

Market Chatter: Novo Nordisk Halts Two More Ziltivekimab Trials

MT Newswires Live

Amgen Shares Down 5.4% Premarket; Rival Novartis Cholesterol Drug Fails Late-Stage Study

THOMSON REUTERS

Why the Dow is Being Dragged Down by a Swiss Company's Bad News

AlzeCure Pharma to Present at Aktiedagen Event in Stockholm

Novo Nordisk (0QIU) Receives a Hold from Barclays

Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports

Yen advances to six-month high, chip stocks rise

Nicholas Reynolds / Bloomberg

Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint

Novo Nordisk (NVO) Hit by Another Heart Drug Setback

Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market

Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial

The Second Act of Biotech

ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review

Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors

Novartis India to Acquire 'Minipress' Trademarks from Pfizer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BK4599/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1569.7671,"timestamp":1788983999999,"preClose":1572.5367,"halted":0,"volume":49629594,"delay":0,"changeRate":-0.001761,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-2.769653,"latestTime":"09-09 16:00:00 EDT","open":1572.5941,"high":1588.4376,"low":1566.7208,"amount":4817092568.939188,"amplitude":0.01381,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789047000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.43172,"peRate":27.673423,"turnoverRate":0.004666,"increases":2,"decrements":5,"flats":0,"marketCap":1637815062464,"floatMarketCap":1570994756032},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1588.4376,"amplitude":0.01381,"preClose":1572.5367,"low":1566.7208,"pbRate":"9.43172","latestPrice":1569.7671,"volume":49629594,"delay":0,"open":1572.5941,"prevYearClose":1494.5856,"prevWeekClose":1629.0011,"prevMonthClose":1629.2258,"prevQuarterClose":1614.7615,"fiveDayClose":1635.7329,"twentyDayClose":1670.7748,"sixtyDayClose":1547.1433,"secType":"PLATE","market":"US","turnoverRate":0.004666,"peRate":27.673423,"marketCap":1637815062464,"floatMarketCap":1570994756032,"timestamp":1788983999999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":2,"down":5,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665432460","title":"Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665432460","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665432460?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:00","pubTimestamp":1788861600,"startTime":"0","endTime":"0","summary":"BEAM-302 Continues to Demonstrate Potential as One-time Treatment for Both Lung and Liver Manifestations of AATD, with AAT Protein Production Under Normal Physiological Control With Up to 18 Months Fo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357432/0/en/beam-therapeutics-presents-updated-clinical-data-from-the-phase-1-2-trial-of-beam-302-in-alpha-1-antitrypsin-deficiency-aatd-at-the-european-respiratory-society-ers-congress-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAM","BK4139","LU1861559042.SGD","BK4588","EPV","LENZ","ALT","BK4505","BK4556","BK4585","IDNA","BK4535","PRTO","BK4539","BK4599","LU1861558580.USD","BK4611","BK4007","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665147329","title":"Why Amgen Stock is Dropping After Swiss Rival's Trial Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2665147329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665147329?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:53","pubTimestamp":1788861180,"startTime":"0","endTime":"0","summary":"Big Pharma has been scrambling to restock its pipelines this year-so a disappointing trial from one drugmaker can have an outsize knock-on impact for rivals trying to develop similar treatments.That d","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","BK4533","LU0109394709.USD","TBXU","LU2468319806.SGD","PJP","BK4139","LU2089984988.USD","IE0002141913.USD","IBB","IE00B2B36J28.USD","BK4566","LU1061106388.HKD","LU2242646821.SGD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU1983299246.USD","LU1571399168.USD","LU1057294990.SGD","BK4585","LU0289739699.SGD","LU0889565916.HKD","BBH","LU1023059063.AUD","BK4534","IE0009355771.USD","BK4588","AMGN","BIB","IE00BJT1NW94.SGD","LU0320765992.SGD","SG9999001440.SGD","IBBQ","PBE","IE00B4R5TH58.HKD","BK4599","LU2112291526.USD","BK4581","LU2242652126.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665326246","title":"Amgen Falls After Novartis Trial Setback, BMO Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326246","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665326246?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:27","pubTimestamp":1788859626,"startTime":"0","endTime":"0","summary":"BUZZ-Amgen falls after Novartis trial setback, BMO downgrade** Shares of AmgenAMGN.Oslip 4.8% to $416 premarket** Novartis'NOVN.Scholesterol drug failed in a closely watched study,raising concernsfor ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500KO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU2112291526.USD","IBB","BBH","IE0002141913.USD","LU2242652126.USD","IE00B2B36J28.USD","BIB","LU1057294990.SGD","LU1571399168.USD","PJP","LU0109394709.USD","LU1983299246.USD","LU2242646821.SGD","LU0889565916.HKD","LU1023059063.AUD","SG9999001440.SGD","IBBQ","BK4533","BK4599","LU0289739699.SGD","BK4588","LU2468319806.SGD","BK4566","LU0868494617.USD","LU0122379950.USD","AMGN","LU0320765992.SGD","LU0058720904.USD","IE0009355771.USD","TBXU","BK4534","LU1061106388.HKD","IE00BJT1NW94.SGD","PBE","LU2089984988.USD","BK4585","IE00BFTCPJ56.SGD","BK4581","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665832664","title":"Novo Nordisk Phase 3 Trial Meets Primary Endpoint for Child Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2665832664","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665832664?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:12","pubTimestamp":1788858753,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Monday its phase 3 Step Young trial evaluating once-weekly semaglutide in children aged six to under 12 with obesity met its primary endpoint.The treatment produced a superior reduction in body mass index at 68 weeks compared with a placebo, the company said.The study also achieved its secondary endpoint for body mass index classification improvement, resulting in 40.4% of treated patients no longer meeting the criteria for obesity, it said.Safety results aligned with previous trials and showed no adverse effects on growth or pubertal development, Novo Nordisk said.Shares of the company were down 1.2% in Tuesday premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4588","LU1093756168.USD","LU1093756325.SGD","THNR","LU0154236417.USD","BK4532","BK4599","IE00BKVL7J92.USD","PPH","IE00BZ1G4Q59.USD","NVOX","OZEM","BK4585","NVO","NVOC","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665342326","title":"Stocks to Watch: Amgen, Nike, Bloom Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342326","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342326?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:07","pubTimestamp":1788858420,"startTime":"0","endTime":"0","summary":"Amgen : Shares of the biotechnology company, a major contributor to the Dow, shed more than 5% premarket after the Swiss drugmaker Novartis  said an experimental medicine failed to reduce cardiovascular risk in a late-stage clinical trial. Amgen and Eli Lilly  are working on rival treatments. Novartis shares tumbled 10% in Europe, while Eli Lilly shares ticked down.Bloom Energy : The fuel-cell maker is among the companies that will join the S&P 500 later this month, S&P Dow Jones Indices announced late Friday, sending its shares 4% higher premarket. Meanwhile, Nike  will be deleted from the S&P 100. Its shares edged lower premarket.Coinbase Global , Robinhood Markets , Strategy : Shares of companies tied to cryptocurrencies retreated in premarket trading as bitcoin's price slipped more than 1% to trade below $78,500.GameStop  is set to report earnings after markets close.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["3SMI.UK","LU0310800379.SGD","MSTZ","HOOX","SMST","HOII","LU1064131342.USD","BK4554","BK4551","IE0002141913.USD","MSTR","HOOI","BK4578","LU1861558580.USD","IE00BFXG0V08.USD","COII","LU0823411888.USD","MSTY","LU2112291526.USD","LU0052756011.USD","IE0009355771.USD","LU0128525929.USD","07711","CNRG","COIA","07799","FINX","LU2249611893.SGD","TBXU","LU0444973449.USD","LU0889565916.HKD","LU2089984988.USD","ROBN","IE00BYQQ9H92.USD","COIX","IBLC","BK4023","LU0868494617.USD","LU2360107671.USD","BK4539","BK4541","BLCK","ICLN","LU1303367103.USD","LU0208291251.USD","MSTP","MSII","LU0823414551.USD","HOOG","ICOI","COIO","3LMI.UK","09799","CONL","FIAT","GME","BK4007","LU0058720904.USD","LU0476273544.USD","LU0070302665.USD","FDIG","LU1571399168.USD","09711","BITQ","LU0029864427.USD","SMI3.UK","IE00BJJMRZ35.SGD","HOOD","LU0109394709.USD","IAI","WATS","OWNB","BK4127","LU1267930573.SGD","BK4533","VTWG","BK4600","LU2468319806.SGD","LU0128525689.USD","BK4588","LU1815336760.USD","BK4566","AMGN","NKE","COIW","BEZ","04332","VCLN","GMEC","BIB","LU1061106388.HKD","LU2543165471.USD","APED","LU2506951792.HKD","MSST","LU1983299246.USD","LU0320765489.SGD","LU0289739699.SGD","SMOG","BK4534","COYY","IE00BJT1NW94.SGD","LU1988902786.USD","CTEC","BE","IGME","MSTK","COIG","LU0792757196.USD","LU2294711713.HKD","WNTR","CONI","UPGR","LU2264538146.SGD","BK4112","CRPT","BK4595","LU1861220207.SGD","BK4596","BK4532","BK4561","HOOC","FRNW","LU0320765992.SGD","BEX","IE00B4R5TH58.HKD","LU0786609619.USD","MSTC","BK4558","BK4599","BK4577","LU0823414478.USD","LU1267930227.SGD","MSTU","SG9999001440.SGD","STYL","IE0009354923.USD","BEC","MSOO","IBB","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU1861217088.USD","07311","07399","MSTX","LU0708994859.HKD","PPH","COIN","CONY","BEG","BK4547","MTYY","BK4516","LU0957808578.USD","PBE","LU2098885051.SGD","GMEU","LMI3.UK","MEDX","HOYY","LU2357125470.USD","BK4139","LU2242646821.SGD","CONX","SIMS","IBBQ","LU1267930813.SGD","MSDD","MSTY.UK","LU0122379950.USD","09311","BKCH","BK4076","LU0211331839.USD","NVS","LU1057294990.SGD","BK4535","MST","BK4182","HODU","PJP","LU1642822529.SGD","IBAT","LU2242652126.USD","ZAP","BK4581","09399","BK4585","DAPP","IMST","GMEY","BPAY","HOOZ","LU1861559042.SGD","LU0889566641.SGD","EGGY","LU1023059063.AUD","BBH","LU0310800965.SGD","HOOY","BK4146","MSTW","LU0444971666.USD","HOOW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665325786","title":"Market Chatter: Novo Nordisk Halts Two More Ziltivekimab Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2665325786","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665325786?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:57","pubTimestamp":1788857878,"startTime":"0","endTime":"0","summary":"Novo Nordisk  has stopped two additional trials of its experimental cardiovascular drug, ziltivekimab, after an independent committee found a low chance they would produce a different result from an earlier failed study, Reuters reported Monday.The trials, which tested the drug in heart failure patients, will end early, the company told MT Newswires. It added that patients will continue through to their 3-months follow-up as already planned.Novo said its trial testing ziltivekimab in an acute setting following a heart attack will continue as planned with results expected in H1 2027.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["THNR","NVOX","IE00BKVL7J92.USD","BK4007","NVO","NVOH","BK4588","IE00BZ1G4Q59.USD","PPH","NVOC","BK4585","OZEM","BK4532","LU1093756325.SGD","LU1093756168.USD","BK4599","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665230393","title":"Amgen Shares Down 5.4% Premarket; Rival Novartis Cholesterol Drug Fails Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665230393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665230393?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:27","pubTimestamp":1788856044,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500JB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1983299246.USD","SG9999001440.SGD","LU2242646821.SGD","LU1571399168.USD","LU0868494617.USD","PJP","LU0289739699.SGD","IE00BJT1NW94.SGD","BK4139","BK4533","LU0320765992.SGD","IE00BFTCPJ56.SGD","IBB","IE00B2B36J28.USD","LU1057294990.SGD","BK4581","AMGN","LU2089984988.USD","BK4585","BBH","PBE","BK4588","LU0889565916.HKD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2112291526.USD","LU2242652126.USD","TBXU","LU0109394709.USD","LU2468319806.SGD","IE0002141913.USD","LU0122379950.USD","BK4534","BK4566","LU0058720904.USD","BIB","LU1023059063.AUD","IBBQ","LU1061106388.HKD","BK4599","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665532340","title":"Why the Dow is Being Dragged Down by a Swiss Company's Bad News","url":"https://stock-news.laohu8.com/highlight/detail?id=2665532340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665532340?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:15","pubTimestamp":1788855300,"startTime":"0","endTime":"0","summary":"Bad news from Swiss pharmaceutical giant Novartis was weighing on the Dow on Tuesday.Investors returning from the Labor Day break could be forgiven for wondering if their eyes were deceiving them, but","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","BK4533","IE00B4R5TH58.HKD","BK4581","LU1983299246.USD","LU2112291526.USD","LU0889565916.HKD","LU2089984988.USD","BK4585","BK4588","LU1061106388.HKD","IE00B2B36J28.USD","IE0002141913.USD","LU0289739699.SGD","IBB","PJP","LU1057294990.SGD","BK4139","LU0058720904.USD","IE0009355771.USD","LU0109394709.USD","LU0320765992.SGD","MEDX","PPH","TBXU","IE00BFTCPJ56.SGD","BK4578","AMGN","LU1023059063.AUD","LU0320765489.SGD","BK4007","LU0868494617.USD","BBH","BK4599","LU0070302665.USD","IE00BJJMRZ35.SGD","PBE","LU0211331839.USD","BK4534","LU1571399168.USD","NAMS","IBBQ","BK4532","LU2242652126.USD","LU0122379950.USD","NVS","LU0208291251.USD","LU2468319806.SGD","BK4566","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665323952","title":"AlzeCure Pharma to Present at Aktiedagen Event in Stockholm","url":"https://stock-news.laohu8.com/highlight/detail?id=2665323952","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665323952?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:03","pubTimestamp":1788854584,"startTime":"0","endTime":"0","summary":"AlzeCure Pharma to present at Aktiedagen event in StockholmAlzeCure will present at Aktiespararna’s Aktiedagen in Stockholm on Sept. 15.CEO Martin Jnsson is scheduled to speak at 16:25 CEST at Birger ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL83QQ0r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU2089984988.USD","IXJ","LU1988902786.USD","LU0266013472.USD","LU0210536198.USD","LU2468319806.SGD","LU2756315318.SGD","MEDX","LU0820562030.AUD","LU1814569148.SGD","LU0943347566.SGD","LU1280957306.USD","LU0354030511.USD","LU2236285917.USD","LU0640476718.USD","SG9999015978.USD","IE00B7KXQ091.USD","LU2361044865.SGD","LU1127390331.HKD","BK4585","LU2063271972.USD","LU0323591593.USD","LU0353189680.USD","LU1868836914.USD","LU0823416689.USD","FTXH","IE00B4JS1V06.HKD","LU0094547139.USD","LU2357305700.SGD","SG9999001176.USD","LU2896262040.SGD","SG9999014914.USD","IE00B4R5TH58.HKD","LU2168564065.EUR","LU1691799644.USD","LU1720051108.HKD","LU2213496289.HKD","LU2271345857.HKD","SG9999013999.USD","LU1868837300.USD","IE00BKPKM429.USD","LU0786609619.USD","LU1983299246.USD","LU2108987350.USD","LU1551013425.SGD","LU2746668974.SGD","SG9999015945.SGD","SGXZ57979304.SGD","SGXZ81514606.USD","IE00BK4W5L77.USD","LU0456855351.SGD","HRTS","LU2087625088.SGD","VHT","AGNG","LU0417517546.SGD","BK4007","LU0096364046.USD","LU0471298694.HKD","LU2265009873.SGD","LU1868837136.USD","LU2111349929.HKD","LU2360106947.USD","LU2324357040.USD","IE00BK4W5M84.HKD","LU0234572021.USD","LU0708995401.HKD","IE00B1XK9C88.USD","LU0820561909.HKD","SG9999014880.SGD","LU0787776722.HKD","LU0006306889.USD","LU0256863902.USD","RXL","LU1323610961.USD","GB00BDT5M118.USD","LU2237443978.SGD","LU0882574139.USD","LU1623119135.USD","LU2211815571.USD","LU0109394709.USD","IE0009355771.USD","JDOC","LU0158827948.USD","LU1551013342.USD","LU2746668461.USD","LU2237443382.USD","LU0256863811.USD","LLYX","IE00BFTCPJ56.SGD","LU2456880835.USD","TMED","LU2237443622.USD","LU2237443549.SGD","LU0432979614.USD","LU0174119429.USD","LU2168564222.USD","LU1868836591.USD","LU1712237335.SGD","IHE","LU0058720904.USD","LU2237443465.HKD","BK4581","LU2552382058.USD","IE0001KFT4U8.USD","LU1917777945.USD","SG9999018865.SGD","IE00BJT1NW94.SGD","LU0203202063.USD","LU1989771016.USD","LU1035775433.USD","LLY","LU2237438978.USD","LU0320765992.SGD","LU0225283273.USD","LU2552382215.SGD","IE0002141913.USD","LU2168563687.JPY","LU2756315664.SGD","LU0820561818.USD","LU0203201768.USD","LU2462591350.SGD","LU0158827781.USD","LU2028103732.USD","LU2602419157.SGD","LU0683600562.USD","IYH","LU2023250330.USD","OZEM","IE00BFSS8Q28.SGD","SGXZ51526630.SGD","LU0316494557.USD","LU0079474960.USD","LU1868836757.USD","LU2491050154.USD","LU1291159041.SGD","LU2471134796.USD","LU0672654240.SGD","LU2471134879.HKD","SG9999014906.USD","SGXZ31699556.SGD","BK4516","LU1979441026.SGD","IE00BWXC8680.SGD","LU1804176565.USD","IE0004445239.USD","IE00B1BXHZ80.USD","LU2237443895.HKD","LU1069344957.HKD","LU2361044949.HKD","BK4588","LU1093756168.USD","SG9999018857.SGD","LU0109391861.USD","ELIS","LU2471134523.USD","SG9999014898.SGD","IE00BJJMRZ35.SGD","FHLC","LU2023250504.SGD","THNR","LU0823434583.USD","LU0889565916.HKD","LU1267930730.SGD","LU0354030438.USD","LU2361045086.USD","LU2491049909.HKD","PJP","LU2023251221.USD","LU0320765059.SGD","LU2417539215.USD","SG9999015986.USD","LU0198837287.USD","LU0238689110.USD","LU2461242641.AUD","LU0133085943.USD","LU1629891620.HKD","ILDR","SG9999015952.SGD","LU0114720955.EUR","XLV","IE00BFSS7M15.SGD","LU2462157665.USD","SG9999001176.SGD","LU1145028129.USD","IE00BJLML261.HKD","LU1548497426.USD","LU0353189763.USD","BK4534","LU0882574055.USD","LU0385154629.USD","LU0823434740.USD","LU2168564495.EUR","LU2089283258.USD","BK4599","LLII","LU2264538146.SGD","LU1064131342.USD","SGXZ99366536.SGD","MEDI","LU1974910355.USD","LU1093756325.SGD","WDNA","LU0345770993.USD","LU0106261372.USD","MHIP","GDOC","LU0061475181.USD","IE0004445015.USD","LU0289739699.SGD","LU0964807845.USD","CANC","IE00BKDWB100.SGD","LU1232071149.USD","LU2750360641.GBP","LU2471134952.CNY","BK4533","LU0345770308.USD","LU2750360997.AUD","LU0097036916.USD","IE00BJJMRY28.SGD","IE0005OL40V9.USD","IE00B775H168.HKD","LU0466842654.USD","LU1720051017.SGD","TRUH","LU2491050071.SGD","IE00BN29S564.USD","ELIL","LU2168564149.EUR","LU2112291526.USD","LU2552382132.HKD","LU1061106388.HKD","LU2089284900.SGD","LU1023059063.AUD","CURE","LU2106854487.HKD","LU0122379950.USD","IE00BJJMRX11.SGD","LU0689472784.USD","SG9999017495.SGD","PPH","LU1057294990.SGD","LLYZ","LU1366192091.USD","LU0471298777.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665328428","title":"Novo Nordisk (0QIU) Receives a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2665328428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665328428?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:25","pubTimestamp":1788852330,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Hold rating on Novo Nordisk today and set a price target of DKK300.00. According to TipRanks, Gordon...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOC","BK4007","THNR","BK4532","NVO","IE00BKVL7J92.USD","NVOH","PPH","BK4585","OZEM","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4588","BK4599","NVOX","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665631001","title":"Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2665631001","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665631001?lang=en_us&edition=fundamental","pubTime":"2026-09-08 05:40","pubTimestamp":1788817216,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) has halted two trials testing if ziltivekimab, its experimental heart disease medicine, would help patients with heart failure, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-halts-two-trials-testing-ziltivekimab-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-halts-two-trials-testing-ziltivekimab-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOH","NVOX","BK4585","IE00BZ1G4Q59.USD","NVOC","PPH","IE00BKVL7J92.USD","OZEM","THNR","BK4599","BK4532","LU1093756168.USD","BK4588","LU1093756325.SGD","LU0154236417.USD","NVO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376683","title":"Yen advances to six-month high, chip stocks rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376683","media":"Nicholas Reynolds / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376683?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:14","pubTimestamp":1788804840,"startTime":"0","endTime":"0","summary":"The yen extended Monday's advance to reach the strongest level since February, aided by rising expectations of a Bank of Japan interest-rate increase next week.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/highlight/stocks-asia-poised-edge-down-yen-focus?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/highlight/stocks-asia-poised-edge-down-yen-focus?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["LU0342679015.USD","IE00BFXG1179.USD","IXG","LU2237957811.SGD","LU0069063385.USD","IE0002270589.USD","LU0957791311.USD","BK4567","LU1267930813.SGD","LU1989764664.SGD","LU2552382215.SGD","LU0234570918.USD","LU2087625088.SGD","LU0149725797.USD","LU0868494708.USD","LU2456880835.USD","LU2237443382.USD","LU0082616367.USD","LU1244550577.SGD","LU1261432733.SGD","SORCLmain","IE00BFMHRM44.USD","LU0267386448.USD","LU2326559502.SGD","LU0314106906.USD","LU1119994496.HKD","LU0238689110.USD","IE00BMPRXQ63.HKD","BK4022","IE00BZ199S13.USD","LU1548497426.USD","LU0964807845.USD","LU2237443465.HKD","LU2430703251.USD","LU2108987350.USD","LU1366333091.USD","TDIV","LU1235294995.USD","IE00BN8TJ469.HKD","IE00BQXX3C00.GBP","LU1032466523.USD","LU0353189680.USD","LU2168564495.EUR","FNCL","LU0211331839.USD","LU0048584097.USD","IE00BWXC8680.SGD","BK4023","LU0545039389.USD","LU0203345920.USD","IE00BJLML261.HKD","LU1316542783.SGD","LU0552385451.USD","LU0985489474.SGD","LU2054465674.USD","ORCS","LU2106854487.HKD","LU0081259029.USD","LU2896262040.SGD","LU2360106780.USD","LU0068578508.USD","UBRL","LU0965509283.SGD","LU0314104364.USD","LU1244550221.USD","LU0433182093.SGD","LU1668664300.SGD","LU0976567544.SGD","LU0943347566.SGD","LU1934455277.USD","LU0234572021.USD","LU2089283258.USD","LU2168563687.JPY","SG9999015945.SGD","XLF","LU1551013342.USD","SG9999015986.USD","LU0130102774.USD","LU2168564222.USD","LU2264538146.SGD","LU1162221912.USD","FTXO","LU1934455194.USD","LU0109392836.USD","LU1429558221.USD","IE00BYQQ9H92.USD","LU0792757196.USD","LU2125154778.USD","LU1935043536.SGD","LU1815333072.USD","BK4007","LU1974910355.USD","LU1894683264.USD","LU2552382132.HKD","UBEW","LU0708995401.HKD","LU1852331112.SGD","ORCZ","PPH","LU1935042991.SGD","IE00B7SZLL34.SGD","LU0323591593.USD","LU2168564065.EUR","LU1093756168.USD","BK4230","LU1823568750.SGD","LU1363072403.SGD","LU0265550946.USD","LU1551013425.SGD","LU1720051108.HKD","LU1035773651.USD","LU2860962120.EUR","LU0320765646.SGD","LU0690374615.EUR","LU2357627491.SGD","LU0211327993.USD","BK4535","LU2237443549.SGD","TPOR","LU0345774391.USD","LU1633808545.USD","BK4207","LU0211326755.USD","LU0106831901.USD","BK4538","LU0215105999.USD","LU2317271919.USD","BK4534","LU2237443622.USD","LU0157215616.USD","LU0353189763.USD","IE00BJTD4V19.USD","LU0648001328.SGD","IE00BKVL7J92.USD","LU0882574139.USD","LU1366192091.USD","LU2430703095.HKD","LU2417539215.USD","BK4527","LU0642271901.SGD","SG9999003800.SGD","LU0070302665.USD","LU1935042488.USD","LU0056508442.USD","ADBE","BK4504","LU0889565833.HKD","IE00BDCRKT87.USD","LU0689472784.USD","LU2357305700.SGD","SG9999017495.SGD","LU2023250330.USD","LU0859254822.USD","LU2125154935.USD","BK4588","SG9999000418.SGD","LU2250418816.HKD","LU0154236417.USD","LU2756315318.SGD","LU0057025933.USD","LU0820561909.HKD","IE00BHPRN162.USD","IE00B1XK9C88.USD","UYG","LU0256863811.USD","LU0661504455.SGD","BK4532","LU2746668461.USD","LU2210149790.SGD","LU1629891620.HKD","SG9999018865.SGD","NVOH","LU1003077747.HKD","IE00BBT3K403.USD","LU0289961442.SGD","LU0868494617.USD","SG9999014914.USD","LU0109391861.USD","IGV","OGIG","LU0949170772.SGD","LU0971096721.USD","LU1267930490.SGD","NVOX","LU2168564149.EUR","IYG","LU1435385759.SGD","IE00BQXX3F31.USD","LU1037948897.HKD","ORAC","NVO","LU0289960550.SGD","LU0965509101.SGD","ORCU","LU0175139822.USD","SG9999002224.SGD","LU1201861249.SGD","LU0738911758.USD","LU0965509010.AUD","LU2023250843.SGD","LU0557290698.USD","TFNS","IE00BFXG0V08.USD","LU1861219969.SGD","TRUF","IE0004445239.USD","LU2360032135.SGD","LU1267930730.SGD","LU1778281490.HKD","BK4551","LU1496350502.SGD","LU1935043023.USD","LU1720051017.SGD","LU1989772923.USD","LU2360107325.USD","IE00B3S45H60.SGD","LU2505996509.AUD","LU1674673428.USD","LU1670627923.USD","GB00B4QBRK32.GBP","LU0006306889.USD","IE0034235188.USD","ORCX","LU2023251221.USD","LU0640476718.USD","LU0345769128.USD","IE00B775SV38.USD","LU1917777945.USD","LU1815336760.USD","LU1914381329.SGD","SG9999014880.SGD","LU2023250504.SGD","LU1093756325.SGD","LU1244550494.USD","LU0310799852.SGD","LU1712237335.SGD","BK4585","BK4543","LU1064131342.USD","LU0889566641.SGD","LU1803068979.SGD","LU0820561818.USD","LU0472753341.HKD","LU2244417387.USD","LU0127658192.USD","IE00B19Z3581.USD","IE00BMPRXR70.SGD","LU1988902786.USD","LU2543165471.USD","LU0345774631.USD","LU0719512351.SGD","LU0690374961.EUR","LU0320765489.SGD","LU0496365809.HKD","LU0980610538.SGD","SG9999002232.USD","LU0203347892.USD","IE00BKDWB100.SGD","LU1674673691.USD","LU0683600562.USD","WNDR","LU1489326972.SGD","SGXZ81514606.USD","ADBG","LU1037948541.HKD","KBWB","LU0106261372.USD","LU1934455863.HKD","LU1691799644.USD","LU1145028129.USD","IE00BK4W5M84.HKD","LU0211328371.USD","SG9999014898.SGD","LU2552382058.USD","IE00BYXW3230.USD","LU2592432038.USD","SG9999001424.SGD","SG9999018857.SGD","LU0107464264.USD","LU2211815571.USD","IE00B1BXHZ80.USD","LU0965508806.USD","LU1084165304.USD","LU2089284900.SGD","IE000M9KFDE8.USD","NVOC","LU1116320901.HKD","LU0444971666.USD","IE0034235295.USD","IE00BK4W5L77.USD","BK4528","LU1046421795.USD","JPO","LU2430703178.SGD","LU0345769631.USD","LU0444973449.USD","LU1642822529.SGD","LU0289739343.SGD","LU0170899867.USD","IE00B5TLWC47.USD","LU0061474960.USD","LU1069347547.HKD","LU2236285917.USD","SGXZ51526630.SGD","BK4581","BK4592","LU0511384066.AUD","LU0211326839.USD","LU1670628061.USD","LU2505996681.GBP","IE00BDRTCR15.USD","LU0820562030.AUD","LU1496350171.SGD","IYF","LU0320765059.SGD","SG9999011175.SGD","SG9999015952.SGD","LU1814569148.SGD","SG9999014906.USD","LU0672654240.SGD","BK4505","IE00BLSP4452.SGD","IE00BZ1G4Q59.USD","LU2237957902.USD","LU0348723411.USD","LU2458330169.SGD","LU1983260115.SGD","LU0476273544.USD","LU0158827948.USD","SGXZ99366536.SGD","BK4536","BK4554","ORCL","GB00B4LPDJ14.GBP","LU0198837287.USD","LU2213496289.HKD","LU2237443978.SGD","LU2746668974.SGD","SGXZ31699556.SGD","LU0208291251.USD","LU2381873111.SGD","LU0256863902.USD","LU2095319765.USD","BK4533","LU0878866978.SGD","IE00BQXX3D17.EUR","LU2242649171.HKD","VFH","LU2210150020.SGD","LU2237438978.USD","BK4566","LU2404859741.USD","SG9999015978.USD","LU2404859667.USD","LU1280957306.USD","FDRV","IE00BMPRXN33.USD","BK4097","LU0553294199.USD","LU2458330243.SGD","JPM","LU1935042215.USD","THNR","LU0251132253.USD","LU1623119135.USD","LU2756315664.SGD","IE0009356076.USD","LU1116320737.USD","LU0787776722.HKD","LU0187121727.USD","LU2462157665.USD","IE00B5949003.HKD","OZEM","LU0417517546.SGD","BK4550","IE00BJTD4N35.SGD","LU2237443895.HKD","LU0861579265.USD","LU1989764748.USD","IE00BLSP4239.USD","LU0942090050.USD","LU1506573853.SGD","LU0345770993.USD","GB00BDT5M118.USD","BK4599","IE0034235303.USD","IYT","LU0265550359.USD","ADBU","JPMO","IE00B19Z9505.USD","UBER","LU1861214812.USD","LU0957808578.USD","LU1894683348.USD","LU0345770308.USD","IE00B19Z3B42.SGD","BK4516","BK4503","LU2097829019.USD","LU1989772840.SGD","LU0210536198.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665109773","title":"Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2665109773","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665109773?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:10","pubTimestamp":1788804610,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) announced first results from the STEP Young phase 3 trial, evaluating once-weekly semaglutide in combination with a reduced-calo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-step-young-phase-3-trial-met-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-step-young-phase-3-trial-met-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOH","LU1093756168.USD","OZEM","NVOX","PPH","BK4532","BK4585","THNR","BK4588","BK4599","LU1093756325.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4007","NVO","NVOC","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665862310","title":"Novo Nordisk (NVO) Hit by Another Heart Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2665862310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665862310?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:56","pubTimestamp":1788800218,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) has halted two late‑stage studies of its experimental heart drug ziltivekimab, marking a major setback in its push into cardiov...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-nvo-hit-by-another-heart-drug-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-nvo-hit-by-another-heart-drug-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4599","BK4532","BK4007","NVO","LU1093756168.USD","OZEM","THNR","BK4588","NVOC","NVOH","PPH","LU0154236417.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVOX","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665731749","title":"Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665731749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665731749?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:02","pubTimestamp":1788796920,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B were flat  at DKK298.95 Monday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 0.3% to 2,710.84.The stock's rise  snapped a two-day losing streak.The company closed DKK111.00 short of its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 1,797,150, compared to the 50-day average trading volume of 4,122,224.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","OZEM","THNR","LU1093756168.USD","NVOX","BK4588","IE00BZ1G4Q59.USD","NVOC","BK4532","PPH","LU1093756325.SGD","IE00BKVL7J92.USD","LU0154236417.USD","BK4599","NVO","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665131175","title":"Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665131175?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:32","pubTimestamp":1788784376,"startTime":"0","endTime":"0","summary":"Novo Nordisk’s ($NVO) shares in Copenhagen edged lower on Monday afternoon. This came even after the Danish pharma giant said in a statement that i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","IE00BKVL7J92.USD","LU0154236417.USD","THNR","LU1093756168.USD","LU1093756325.SGD","NVOX","BK4585","BK4599","BK4007","NVO","NVOH","OZEM","NVOC","IE00BZ1G4Q59.USD","BK4588","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665531933","title":"The Second Act of Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2665531933","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665531933?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:08","pubTimestamp":1788779310,"startTime":"0","endTime":"0","summary":"Pfizer sells dopamine. Moderna made the COVID vaccine. Both are betting their next decade on medicines that barely existed when their stocks peaked...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-second-act-of-biotech?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-second-act-of-biotech?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999002232.USD","BK4599","SG9999002224.SGD","BK4550","WDNA","BK4139","BK4532","LU0234572021.USD","BK4581","LU1057294990.SGD","LU1066053197.SGD","MRNX","LU1883839398.USD","LU0225771236.USD","BK4007","BK4592","BK4533","LU0985481810.HKD","LU1066051498.USD","LU1894683348.USD","BK4568","IE000M9KFDE8.USD","LU2596442595.SGD","BK4501","BK4588","IE00BLSP4452.SGD","LU1023059063.AUD","MRNA","MRNY","IDNA","GNOM","LU0289739699.SGD","SG9999013999.USD","IE00B19Z3581.USD","LU0321505868.SGD","LU0321505439.SGD","LU0868494617.USD","SG9999011175.SGD","BK4585","LGHT","SG9999001176.SGD","SG9999003800.SGD","LU0170899867.USD","BK4551","LU0225284248.USD","LU0306806265.USD","IE00BBT3K403.USD","LU0122379950.USD","BK4534","BK4548","IE00B19Z3B42.SGD","LU0456855351.SGD","LU1894683264.USD","PFE","IE00BLSP4239.USD","SG9999001176.USD","SGXZ57979304.SGD","OZEM","IE0002270589.USD","LU0306807586.USD","LU0058720904.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665023390","title":"ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2665023390","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665023390?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:35","pubTimestamp":1788770131,"startTime":"0","endTime":"0","summary":"ASB Ventures-backed Boundary Zhikong’s Navista eVTOL navigation system enters CAAC airworthiness reviewShenzhen ASB Ventures portfolio company Boundary Intelligent Control secured CAAC acceptance of a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL7rkwzT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B775H168.HKD","LU2746668461.USD","LU2023250330.USD","TRUH","LU1267930730.SGD","THNR","BK4534","SG9999014880.SGD","LU2462157665.USD","IE00BJLML261.HKD","XLV","LU2271345857.HKD","IE0002141913.USD","LU0823434740.USD","LU1145028129.USD","BK4585","BK4211","LU1868836757.USD","LU1868836591.USD","LU1868837136.USD","LU2237438978.USD","LU2471134523.USD","LU0266013472.USD","LU0094547139.USD","LU0109391861.USD","LU1720051108.HKD","IXJ","IE00BFTCPJ56.SGD","LU0174119429.USD","SG9999018857.SGD","LU2236285917.USD","LU0203201768.USD","LU1366192091.USD","ASB","BK4516","LU0061475181.USD","LU2468319806.SGD","SG9999017495.SGD","FTXH","IE00BN29S564.USD","LU2265009873.SGD","LU2237443895.HKD","LU2461242641.AUD","IE00BJJMRZ35.SGD","LU0823434583.USD","LU0882574139.USD","LU1804176565.USD","IE00BJJMRY28.SGD","IYH","LU1093756325.SGD","HRTS","SGXZ81514606.USD","IE0001KFT4U8.USD","SGXZ51526630.SGD","FHLC","SGXZ57979304.SGD","IE0005OL40V9.USD","LU0345770308.USD","LU0109394709.USD","BK4599","ILDR","LU0133085943.USD","IE00B2B36J28.USD","LU0203202063.USD","IE00BKDWB100.SGD","LU0786609619.USD","SG9999015952.SGD","LU1623119135.USD","LU2087625088.SGD","MEDI","LU0198837287.USD","ELIS","LU1720051017.SGD","IE00BFSS8Q28.SGD","LU1551013425.SGD","IE0004445239.USD","LU1064131342.USD","IE00BKPKM429.USD","LU0289739699.SGD","LU2750360641.GBP","LU0471298694.HKD","LU0820562030.AUD","IE00BK4W5L77.USD","BK4007","LU2213496289.HKD","LU0320765059.SGD","LU0964807845.USD","LU1548497426.USD","BK4533","LU0889565916.HKD","LU0225283273.USD","LU0238689110.USD","LU0456855351.SGD","IE00B4R5TH58.HKD","LU2361045086.USD","LU1974910355.USD","LU0158827781.USD","SG9999015945.SGD","LU0006306889.USD","VHT","ELIL","LU0820561909.HKD","LU1057294990.SGD","SG9999014898.SGD","LU0114720955.EUR","LU1868836914.USD","LU1280957306.USD","MEDX","OZEM","LU2360106947.USD","SG9999015986.USD","SG9999014914.USD","LU2063271972.USD","LU2491050071.SGD","LU0354030438.USD","GB00BDT5M118.USD","LU2552382132.HKD","LU1035775433.USD","IHE","LU0820561818.USD","LU0385154629.USD","LU0353189680.USD","LU1127390331.HKD","LU2237443549.SGD","LU2491050154.USD","PJP","JDOC","BK4581","LU0345770993.USD","LU0417517546.SGD","SG9999014906.USD","LU2264538146.SGD","CURE","LU0787776722.HKD","LU2089284900.SGD","LLYX","IE00BK4W5M84.HKD","WDNA","LU0354030511.USD","TMED","LU0708995401.HKD","LU2023251221.USD","LU2111349929.HKD","LU2237443622.USD","BK4588","LU0256863902.USD","IE00BJJMRX11.SGD","LU2108987350.USD","LU2471134952.CNY","LU0471298777.SGD","LU1291159041.SGD","LU2028103732.USD","LU2237443382.USD","LU2552382058.USD","IE00B7KXQ091.USD","SGXZ99366536.SGD","LU0882574055.USD","IE00B1XK9C88.USD","LU0672654240.SGD","LU2168564495.EUR","LU0210536198.USD","LLY","LU2168564065.EUR","LU2756315318.SGD","LU1232071149.USD","LU2089984988.USD","IE0004445015.USD","LU2756315664.SGD","LU2456880835.USD","LU1629891620.HKD","LU1069344957.HKD","MHIP","LU0079474960.USD","LU0122379950.USD","IE0009355771.USD","LU2361044949.HKD","LU2896262040.SGD","LU0058720904.USD","LU1917777945.USD","LU1988902786.USD","LU0106261372.USD","LU0320765992.SGD","IE00B4JS1V06.HKD","LU1989771016.USD","RXL","SG9999013999.USD","LLYZ","IE00BJT1NW94.SGD","AGNG","LU0353189763.USD","LU2211815571.USD","LU0689472784.USD","LU0158827948.USD","LU1814569148.SGD","LU2324357040.USD","LU1323610961.USD","IE00BFSS7M15.SGD","LU2106854487.HKD","LU0097036916.USD","LU0823416689.USD","LU2746668974.SGD","LU2471134879.HKD","LU2361044865.SGD","LU1979441026.SGD","LU2237443978.SGD","LU0943347566.SGD","LLII","SG9999001176.USD","IE00BWXC8680.SGD","LU2023250504.SGD","PPH","LU2552382215.SGD","LU1061106388.HKD","LU2357305700.SGD","LU2168564222.USD","LU2089283258.USD","LU1712237335.SGD","LU1868837300.USD","LU1691799644.USD","LU0256863811.USD","LU2237443465.HKD","LU0316494557.USD","LU0683600562.USD","LU2168563687.JPY","SGXZ31699556.SGD","LU2462591350.SGD","LU0234572021.USD","LU1983299246.USD","LU2750360997.AUD","LU2112291526.USD","LU0323591593.USD","CANC","LU2491049909.HKD","LU0640476718.USD","GDOC","LU1093756168.USD","LU1551013342.USD","LU0432979614.USD","LU2417539215.USD","SG9999015978.USD","LU1023059063.AUD","LU0096364046.USD","LU2602419157.SGD","LU0466842654.USD","SG9999001176.SGD","SG9999018865.SGD","LU2471134796.USD","LU2168564149.EUR","IE00B1BXHZ80.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665739003","title":"Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665739003","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665739003?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:32","pubTimestamp":1788769920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.2% to 5.47 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 40% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.1% and Amgen Inc. remained unchanged.Trading volume totaled 42.8 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU2112291526.USD","IE00BZ08YS42.EUR","IBB","BBH","IE0002141913.USD","IE00BZ08YT58.USD","HK0000165453.HKD","LU2242652126.USD","BK1515","IE00B2B36J28.USD","BIB","LU1057294990.SGD","LU1571399168.USD","PJP","01177","LU0109394709.USD","LU1983299246.USD","LU2242646821.SGD","LU0889565916.HKD","LU1023059063.AUD","SG9999001440.SGD","IBBQ","BK4533","BK4599","LU0289739699.SGD","BK1589","BK4588","LU2468319806.SGD","BK4566","LU0868494617.USD","LU0122379950.USD","BK1521","BK1191","AMGN","LU0320765992.SGD","LU0058720904.USD","IE0009355771.USD","TBXU","BK4534","IE00BZ08YR35.GBP","LU1061106388.HKD","IE00BJT1NW94.SGD","PBE","LU2089984988.USD","BK4585","IE00BFTCPJ56.SGD","BK4581","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665397422","title":"Novartis India to Acquire 'Minipress' Trademarks from Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665397422","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665397422?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:43","pubTimestamp":1788767020,"startTime":"0","endTime":"0","summary":"BRIEF-Novartis India To Acquire 'Minipress' Trademarks From PfizerSept 7 (Reuters)-Novartis India LtdNOIN.BO:TO ACQUIRE 'MINIPRESS' TRADEMARKS FROM PFIZERSource text:ID:nBSE74jJ9yFurther company coverage:NOIN.BO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44Y00E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU0456855351.SGD","LU0058720904.USD","MEDX","BK4007","BK4550","LU0070302665.USD","IE00BBT3K403.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU2596442595.SGD","BK4578","IE00B19Z3581.USD","LU0225284248.USD","SGXZ57979304.SGD","BK4568","BK4533","BK4532","SG9999001176.SGD","LU0122379950.USD","LU0306806265.USD","SG9999003800.SGD","IE00BLSP4452.SGD","NVS","LU0211331839.USD","SG9999002224.SGD","BK4588","LU1057294990.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","LU1894683348.USD","LU0225771236.USD","IE00B19Z3B42.SGD","BK4599","LU1066051498.USD","BK4592","LU0321505439.SGD","LU1883839398.USD","LU0985481810.HKD","SG9999013999.USD","LU0306807586.USD","BK4581","IE00B2B36J28.USD","BK4585","IE00BFTCPJ56.SGD","LU0320765489.SGD","IE000M9KFDE8.USD","LU0289739699.SGD","LU0321505868.SGD","IE00BLSP4239.USD","LU0868494617.USD","LU0170899867.USD","LU1894683264.USD","IE0002270589.USD","IE00B3T34201.USD","OZEM","PFE","LU1023059063.AUD","PPH","BK4534","SG9999001176.USD","SG9999002232.USD","SG9999011175.SGD","IE00BJT1NW94.SGD","LU0208291251.USD","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}